BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 19085565)

  • 1. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
    Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
    Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG).
    Woo DH; Jung SJ; Zhu MH; Park CK; Kim YH; Oh SB; Lee CJ
    Mol Pain; 2008 Oct; 4():42. PubMed ID: 18826653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
    Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
    Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.
    Vetter I; Wyse BD; Roberts-Thomson SJ; Monteith GR; Cabot PJ
    Eur J Pain; 2008 May; 12(4):441-54. PubMed ID: 17826200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
    Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
    Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
    McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
    Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of transient receptor potential (TRP) channels by Chinese herbal extracts.
    Zhang Y; Sreekrishna K; Lin Y; Huang L; Eickhoff D; Degenhardt C; Xu T
    Phytother Res; 2011 Nov; 25(11):1666-70. PubMed ID: 21432926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
    Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
    El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
    Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
    Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxy-alpha-sanshool activates TRPV1 and TRPA1 in sensory neurons.
    Koo JY; Jang Y; Cho H; Lee CH; Jang KH; Chang YH; Shin J; Oh U
    Eur J Neurosci; 2007 Sep; 26(5):1139-47. PubMed ID: 17767493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
    J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
    Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
    Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation.
    Klionsky L; Tamir R; Holzinger B; Bi X; Talvenheimo J; Kim H; Martin F; Louis JC; Treanor JJ; Gavva NR
    J Pharmacol Exp Ther; 2006 Oct; 319(1):192-8. PubMed ID: 16844842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
    Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
    Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel.
    Auzanneau C; Norez C; Antigny F; Thoreau V; Jougla C; Cantereau A; Becq F; Vandebrouck C
    Biochem Pharmacol; 2008 Jan; 75(2):476-83. PubMed ID: 17945192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents.
    Verleye M; Gillardin JM
    Pharmacology; 2009; 83(2):116-21. PubMed ID: 19096234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.